Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Regenxbio Inc (NASDAQ: RGNX) was $9.59 for the day, up 4.47% from the previous closing price of $9.18. In other words, the price has increased by $4.47 from its previous closing price. On the day, 0.68 million shares were traded. RGNX stock price reached its highest trading level at $9.82 during the session, while it also had its lowest trading level at $9.01.
Ratios:
Our analysis of RGNX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.05 and its Current Ratio is at 3.05. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.37.
On June 07, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $38.Goldman initiated its Buy rating on June 07, 2024, with a $38 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 01 ’24 when KARABELAS ARGERIS N sold 10,000 shares for $10.11 per share. The transaction valued at 101,052 led to the insider holds 11,286 shares of the business.
KARABELAS ARGERIS N sold 10,000 shares of RGNX for $115,588 on Sep 03 ’24. The Director now owns 11,286 shares after completing the transaction at $11.56 per share. On Aug 01 ’24, another insider, KARABELAS ARGERIS N, who serves as the Director of the company, sold 10,100 shares for $13.51 each. As a result, the insider received 136,454 and left with 11,286 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGNX now has a Market Capitalization of 475137504 and an Enterprise Value of 365488224. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.89 while its Price-to-Book (P/B) ratio in mrq is 1.58. Its current Enterprise Value per Revenue stands at 4.334 whereas that against EBITDA is -1.635.
Stock Price History:
Over the past 52 weeks, RGNX has reached a high of $28.80, while it has fallen to a 52-week low of $8.53. The 50-Day Moving Average of the stock is -6.36%, while the 200-Day Moving Average is calculated to be -32.54%.
Shares Statistics:
RGNX traded an average of 626.58K shares per day over the past three months and 1179630 shares per day over the past ten days. A total of 49.55M shares are outstanding, with a floating share count of 44.84M. Insiders hold about 9.50% of the company’s shares, while institutions hold 90.25% stake in the company. Shares short for RGNX as of 1730332800 were 4909350 with a Short Ratio of 7.84, compared to 1727654400 on 5309395. Therefore, it implies a Short% of Shares Outstanding of 4909350 and a Short% of Float of 12.959999999999999.
